Introduction
============

Second Hand Smoke (SHS), emitted from cigarettes is a known human toxin and carcinogen. It contains over 3000 chemicals out of which at least 50 are known or suspected to be carcinogenic, whilst over 200 are regarded as poisonous \[[@b1-ijerph-05-00125]--[@b2-ijerph-05-00125]\]. Its adverse effects on human health have been well documented and it is generally accepted that there is no safe level of exposure to cigarette smoke \[[@b3-ijerph-05-00125]\]. Tumor genesis, cardiovascular and respiratory diseases amongst others have been shown to develop and worsen in populations exposed to SHS \[[@b4-ijerph-05-00125]--[@b8-ijerph-05-00125]\]. It is also common knowledge that there is no lower threshold for tobacco carcinogenesis, either regarding lung cancer or tumors in other tissues that are indirectly exposed, since carcinogens absorbed in the lung are distributed throughout the body and have been proven to create or aggravate tumor genesis \[[@b9-ijerph-05-00125]--[@b10-ijerph-05-00125]\].

In Greece it is estimated that 40% of the adult population are smokers and as stated in previous articles, and even though legislation regarding tobacco use exists, it is inadequately enforced and in certain cases bluntly ignored by the population \[[@b11-ijerph-05-00125]--[@b13-ijerph-05-00125]\]. One law, which is perceived to be correctly enforced, is the implementation of a smoking ban in health-care service centers such as public and private hospitals, health centers and pharmacies (Health Law 76017) \[[@b14-ijerph-05-00125]\]. According to the legislation (in force since August 2002) smoking is allowed only in designated areas, which should be provided with adequate air circulation for those who wish to smoke. The legislation also covered public services, educational institutions and public transport stations / public vehicles. To date, there is little information regarding the exact extent of exposure to SHS in Greece, especially in areas where health services are provided. Therefore, the purpose of our study was firstly to measure SHS exposure in different areas throughout a large Greek public hospital and furtherly to estimate the excess lung-cancer and heart disease mortality risk of the hospital personnel due to their occupational exposure to SHS.

Methods
=======

Aerosol Measurements and Questionnaire Procedures
-------------------------------------------------

A TSI SidePak AM510 Personal Aerosol Monitor (TSI, Inc., St. Paul, Minnesota, USA) was used to sample and record the levels of respirable suspended particles (RSP) in the air. The SidePak uses a built-in sampling pump to draw air through the device and the particulate matter in the air scatters the light from a laser to assess the real-time concentration of particles less than 2.5 μm in micrograms per cubic meter, or PM~2.5~. Particles of this size are released in significant amounts from burning cigarettes, are easily inhaled deep into the lungs, and are associated with pulmonary and cardiovascular disease and mortality \[[@b15-ijerph-05-00125]\]. SHS is not the only source of indoor particulate matter since dust, cooking and vehicle fumes also of this size. However, PM~2.5~ monitoring is highly sensitive to SHS and elevated levels of such particles can be attributed almost solely to SHS \[[@b16-ijerph-05-00125],[@b17-ijerph-05-00125]\]. Taking into account the background hospital ambient aerosol levels one can calculate the PM~2.5~ levels which are attributed to SHS, following the formula: SHS-RSP levels = measured RSP -- B, where B is the background aerosol level.

The SidePak was calibrated against a light scattering instrument, which had been previously calibrated and used in similar studies. The equipment was set to a ten-second sampling interval, which averages the measurements of the previous 10 seconds. The SidePak's flow rate was set to 1.7 litres per minute to ensure proper operation of the attached 2.5-micron impactor. In accordance with the Global Air Monitoring Study Protocol, a calibration factor of 0.32, which is suitable for tobacco smoke, was applied to all data \[[@b18-ijerph-05-00125]\].

Observational information was also recorded regarding evidence of current or previous smoking in the area, air volume and other factors that might affect the data (such as the use of solvents, and other chemicals). The monitor was strapped on the observer's shoulder, so that the air being sampled was within the occupants' normal breathing zone and sampling was discreet in order not to disturb the patients' and personnel normal behavior. For each clinic or ward, the first and last twenty seconds of logged data were removed because they were averaged with waiting room and stairway air. A total of fifteen minutes were spent in each area or ward inside the hospital throughout which the remaining data points were averaged to provide a mean PM~2.5~ concentration. Measurements took place on weekdays during April 2006, during the morning shift (9 am--3 pm). The University Hospital of Crete, which is located in Heraklion Greece, provides primary and secondary care to the population of Heraklion and tertiary care to the population of Crete and the nearby islands. The study was approved and acknowledged by the management of the Heraklion University Hospital but kept unknown from the staff and patients so as not to temporarily modify their smoking behavior.

Calculating Airborne Nicotine and Excess Lung Cancer Mortality Risk
-------------------------------------------------------------------

According to the equations introduced by Repace et al., ambient aerosol nicotine levels (AANL) can be calculated from SHS-RSP levels (SHS-RSP: nicotine ratio = 10:1) and a workplace airborne nicotine concentration of 7.5 ug/m^3^ gives an excess heart disease and lung cancer risk of 10/1000 and 1/1000 respectively in a linear dose-response relationship over the 40-year working lifetime \[[@b19-ijerph-05-00125]--[@b20-ijerph-05-00125]\]. The developed formula successfully has predicted actual mortality risk in population based studies and has been used previously to estimate excess occupational lung cancer risk and heart disease among hospitality workers \[[@b21-ijerph-05-00125]--[@b23-ijerph-05-00125]\].

Results
=======

Indoor Air Concentrations of SHS-RSP
------------------------------------

[Table 1](#t1-ijerph-05-00125){ref-type="table"} depicts the state of occupational exposure to SHS inside the hospital. The exact SHS-RSP levels differed drastically between each area. No levels of SHS-RSP were measured in only the intensive care unit and in operating theatres with mean SHS-RSP levels of 11 ug/m^3^, even lower than the outdoor reference level of 27 ug/m^3^. On the other hand, in most wards smoking was either noticed or evident. The mean SHS-RSP level of open wards was estimated at 84 ug/m^3^ and ranged between 17 and 141 ug/m^3^ with the lower readings found in children's wards (general paediatrics, paediatric haematology etc).

Staff rest rooms also were measured to have elevated SHS-RSP levels, depending on whether smoking was evident during or before the measurements were taken. In staff rest rooms, in which smoking was evident, SHS-RSP levels averaged 628 ug/m^3^ and in those were smoking was not noticed 17 ug/m^3^. Stairwells and waiting rooms also were found to have elevated SHS-RSP levels of 147 and 211 ug/m^3^, respectively. Inside the hospital premises smoking is permitted only in the smoking room, which has inadequate air ventilation. There, exposure to SHS-RSP was inevitably high, averaging 1448 ug/m^3^. Even higher levels of SHS-RSP exposure, averaging 1461 ug/m^3^, were found in certain changing rooms in which smoking, although prohibited, was observed.

Calculated Nicotine Levels and Estimates of Excess Heart Disease and Lung Cancer Mortality
------------------------------------------------------------------------------------------

Taking into account the average levels of SHS one is exposed to while working in the hospital one can calculate the excess occupational lifetime risk of heart disease and lung cancer due to passive smoke exposure in the hospital.

According to the ambient aerosol to ambient aerosol nicotine level (AANL) transformation formulas, the mean AANL was 8.4 ug/m^3^ (range 1.7 to 14.1 ug/m^3^) in open wards and 16.4 ug/m^3^ (range 2.9 to 90.1 ug/m^3^) in the hospital management wards. [Table 2](#t2-ijerph-05-00125){ref-type="table"} depicts the estimated excess heart disease and lung cancer mortality risk due to SHS exposure in the hospital. On average 1.12 (0.23 to 1.88) workers per 1000 in open wards and 2.35 per 1000 (0.55--12.2) of management staff will die of lung cancer due to hospital SHS exposure. The excess lung cancer mortality risk in the ICU or operating theatres was not calculated because ambient aerosol measurements were even lower than outdoor baseline measurements and therefore could not be attributed to SHS. Excess heart disease mortality was calculated as tenfold that of the excess lung cancer cases and the accumulation of both led to the total excess mortality cases of 12.3 (2.5 to 20.7) and 25.9 per 1000 (6 -- 134) of cases per 1000 per 40 years in open and management wards respectively.

Discussion
==========

The levels of SHS exposure recorded in most areas of the hospital are alarming. It is evident that regulations for tobacco control are not being followed since exposure to SHS was evident in almost all areas. Patients, their relatives and friends, but also personnel were observed smoking during the days the measurements took place. Although waiting rooms and stairways do not have ashtrays and have prominent no-smoking signs, smoking was evident and exposure to SHS for those in waiting rooms was elevated. Personnel were found smoking in their rest rooms and also in their changing rooms so as to avoid being seen and reprimanded. The effects of SHS exposure on human health have been well documented and in this instance would not only affect the state of personnel health but also patients under treatment. Second-hand smoke has been found to worsen asthma attacks, chronic obstructive pulmonary disease, childhood cancer, adult cancer treatment and outcome, and even fertility among women who have undergone recent IVF \[[@b24-ijerph-05-00125]--[@b28-ijerph-05-00125]\].

SHS can now be added to the plethora of health hazards that doctors and nursing staff face. Back pain, long hours and exposure to radiation, latex, nitrous oxide and biological pathogens are just a few dangers that can reduce work efficiency and the health of the practitioners themselves \[[@b29-ijerph-05-00125]--[@b34-ijerph-05-00125]\]. In contrary to the above though, exposure to SHS can be completely avoided if legislated tobacco control measures are followed as designed.

Exposure to SHS in the workplace is not uncommon, especially for workers in hospitality venues, such as bars, cafes and restaurants. Regarding excess lung cancer mortality, similar levels of risk to those found in our study have been noted among workers in betting parlours and bowling alleys in the U.S (1--1.4 per 1000) and in cafes and bars in Spain \[[@b21-ijerph-05-00125]--[@b22-ijerph-05-00125]\]. In comparison to our findings workers in US bars ran a much higher excess risk of up to 14 per 1000 (before the smoking ban), while Hong Kong hospitality workers have also been estimated at running an almost three times higher lung cancer and cardiovascular disease mortality risk in comparison to hospital personnel of our study but one should take into account the completely different setting between hospitality services and health provision services \[[@b23-ijerph-05-00125]\]. Globally, certain populations and specific working groups (as are employees in bars, cafes, casinos, pubs and restaurants) are exposed and subsequently affected by SHS. Implementing smoking bans has been found to reduce both occupational respiratory symptoms and population based risk of acute myocardial infarction and other cardiovascular events and the necessity of their implementation is scientifically warranted \[[@b35-ijerph-05-00125]--[@b36-ijerph-05-00125]\]. To our knowledge this is the first study that clearly demonstrates the connection between non-compliance to tobacco control measures for SHS exposure and mortality risk among workers in a hospital setting.

Certain assumptions were made during aerosol measurements and excess heart disease and lung cancer calculations. It is possible that lifetime exposure to SHS in the hospital differs due to our short window of measurements. It is possible that SHS levels during the afternoon and night shifts might be lower due to the reduction in personnel and visitors. However, the excess mortality risk might not necessarily be lower as we have not taken into account movement between wards and the time spent in staff rest rooms that provide a brief but extremely high exposure to SHS. Although it is difficult to extract generalizable conclusions in regards to other hospitals in Greece this study shows that PM~2.5~ measurements are a valid tool for measuring and monitoring SHS exposure in hospitals and an important means of surveillance of tobacco control legislations.

From our study, we are able to conclude that SHS in a typical hospital in Greece is prevalent and poses a threat to the health of patients and hospital personnel. Even though a policy that bans smoking in hospitals does exist, it is flagrantly ignored. When one considers the excess mortality risk and the immediate adverse health effects of SHS, it is imperative that the legislation that bans smoking within hospitals in Greece be enforced to protect not only patients but also medical and nursing staff from involuntary exposure to SHS and its ramifications.
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###### 

Hospital indoor air concentrations of ETS (SHS-RSP)

  *Area*                            *Mean levels (μg/m^3^)*   *Range (μg/m^3^)*
  --------------------------------- ------------------------- -------------------
  Open wards                        84                        17 -- 141
  Closed wards                                                
    Intensive Care Unit             12                        2 -- 23
    Operating theatres              11                        8 -- 21
  Staff rest rooms                                            
    Smoking during measurements     628                       453 --1842
    Smoking prior to measurements   169                       11 -- 919
    Smoking not noticed             17                        10 -- 42
  Management wards                  164                       29 -- 901
  Waiting Rooms                     211                       91 -- 331
  Main Lobby                        57                        25 -- 84
  Stairwells                        147                       24 -- 253
  Changing rooms                                              
    Smoking noticed                 1461                      1374 -- 2123
    Smoking not noticed^2^          84                        17 -- 141
  Corridors                                                   
    Main                            79                        47 -- 94
    Secondary                       59                        19 -- 98
    Personnel only                  50                        7 -- 104
  Smoking room                      1448                      1051 -- 2084
  Outdoor reference                 27                        \-

###### 

Estimated excess heart disease and lung cancer deaths per 1000 per 40 years due to hospital based SHS exposure[^1^](#tfn1-ijerph-05-00125){ref-type="table-fn"}

                                                                                               *Open wards*   *Closed wards*   *Management wards*
  -------------------------------------------------------------------------------------------- -------------- ---------------- --------------------
  Mean nicotine concentrations[^3^](#tfn3-ijerph-05-00125){ref-type="table-fn"} in (ug/m^3^)   8.4            N/a              17.6
  Range in (ug/m^3^)                                                                           1.7 -- 14.1    N/a              4.1 -- 91.3
  Excess lung cancer deaths                                                                    1.12           N/a              2.35
  Range                                                                                        0.23 -- 1.88   N/a              0.55 -- 12.2
  Excess heart disease deaths                                                                  11.2           N/a              23.5
  Range                                                                                        2.3 -- 18.8    N/a              5.5 -- 122
  Total excess mortality                                                                       12.3           N/a              25.9
  Range                                                                                        2.5 -- 20.7    N/a              6 -- 134

Units of deaths per 1000 persons per 40 years

Mean nicotine concentrations were calculated by using the data from [Table 1](#t1-ijerph-05-00125){ref-type="table"} SHS-RSP: nicotine ratio of 10:1

Total excess mortality = Lung cancer mortality + cardiovascular disease mortality
